Literature DB >> 6718421

Experimental allergic encephalomyelitis, a useful model for multiple sclerosis. A satellite conference of the International Society of Neurochemists. Seattle, Washington, July 16-19, 1983.

.   

Abstract

Entities:  

Mesh：

Year:  1984        PMID： 6718421

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  3 in total

1.  The neuroprotective agent SR 57746A abrogates experimental autoimmune encephalomyelitis and impairs associated blood-brain barrier disruption: implications for multiple sclerosis treatment.

Authors:  B Bourrié; E Bribes; M Esclangon; L Garcia; J Marchand; C Thomas; J P Maffrand; P Casellas
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

2.  Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice.

Authors:  A H Cross; T P Misko; R F Lin; W F Hickey; J L Trotter; R G Tilton
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

3.  Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.

Authors:  A H Cross; T J Girard; K S Giacoletto; R J Evans; R M Keeling; R F Lin; J L Trotter; R W Karr
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.